Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5554)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2015 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dabos KJ, Parkinson JA, Sadler IH, Plevris JN, Hayes PC. 1H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy. World J Hepatol 2015; 7(12): 1701-1707 [PMID: 26140090 DOI: 10.4254/wjh.v7.i12.1701] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i12/1701.htm |
| Number | Citing Articles |
| 1 |
Victoria Liere, Gurkarminder Sandhu, Sharon DeMorrow. Recent advances in hepatic encephalopathy. F1000Research 2017; 6: 1637 doi: 10.12688/f1000research.11938.1
|
| 2 |
Diren Beyoğlu, Jeffrey R. Idle. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020; 10(2): 50 doi: 10.3390/metabo10020050
|
| 3 |
Yumeng Zhang, Min Zhao, Yangyang Liu, Tingting Liu, Chunjie Zhao, Miao Wang. Investigation of the therapeutic effect of Yinchen Wuling Powder on CCl4-induced hepatic fibrosis in rats by 1H NMR and MS-based metabolomics analysis. Journal of Pharmaceutical and Biomedical Analysis 2021; 200: 114073 doi: 10.1016/j.jpba.2021.114073
|
| 4 |
Ming-Ling Chang, Sien-Sing Yang. Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology. Cells 2019; 8(11): 1423 doi: 10.3390/cells8111423
|
| 5 |
Luisa Baker, Bernard Lanz, Fausto Andreola, Javier Ampuero, Anisha Wijeyesekera, Elaine Holmes, Nicolaas Deutz. New technologies – new insights into the pathogenesis of hepatic encephalopathy. Metabolic Brain Disease 2016; 31(6): 1259 doi: 10.1007/s11011-016-9906-y
|
| 6 |
Jian-Xin Song, Lin Zhu, Chuan-Long Zhu, Jin-Hua Hu, Zi-Jian Sun, Xiang Xu, Min-You Xin, Qiong-Fang Zhang, Da-Zhi Zhang, Jia Shang, Jia-Quan Huang, Dong Xu. Acute Exacerbation of Chronic Hepatitis B. 2019; : 91 doi: 10.1007/978-94-024-1603-9_2
|
| 7 |
Daniel Simplicio Torres, Jefferson Abrantes, Carlos Eduardo Brandão-Mello. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86320
|
| 8 |
Yumeng Zhang, Min Zhao, Xue Jiang, Qiaoyu Qiao, Tingting Liu, Chunjie Zhao, Miao Wang. Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.713197
|
| 9 |
Zoe Schofield, Michelle AC Reed, Philip N Newsome, David H Adams, Ulrich L Günther, Patricia F Lalor. Changes in human hepatic metabolism in steatosis and cirrhosis. World Journal of Gastroenterology 2017; 23(15): 2685-2695 doi: 10.3748/wjg.v23.i15.2685
|
| 10 |
Ding Cao, Can Cai, Mingxin Ye, Junhua Gong, Menghao Wang, Jinzheng Li, Jianping Gong. Differential metabonomic profiles of primary hepatocellular carcinoma tumors from alcoholic liver disease, HBV-infected, and HCV-infected cirrhotic patients. Oncotarget 2017; 8(32): 53313 doi: 10.18632/oncotarget.18397
|
| 11 |
Marta Moya, Berta Escudero, Elena Gómez-Blázquez, Ana Belen Rebolledo-Poves, Meritxell López-Gallardo, Carmen Guerrero, Eva M. Marco, Laura Orio. Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke’s encephalopathy: Findings in preclinical models and in a postmortem human case. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.866574
|
| 12 |
Wouter Claeys, Lien Van Hoecke, Sander Lefere, Anja Geerts, Xavier Verhelst, Hans Van Vlierberghe, Helena Degroote, Lindsey Devisscher, Roosmarijn E. Vandenbroucke, Christophe Van Steenkiste. The neurogliovascular unit in hepatic encephalopathy. JHEP Reports 2021; 3(5): 100352 doi: 10.1016/j.jhepr.2021.100352
|
| 13 |
Dan Yang, Min Zhao, Yumeng Zhang, Miao Wang, Chunjie Zhao. Luteolin-β-CD-MOF prevents against acetaminophen-mediated liver damage by controlling ferroptosis through GSH/GPX4/SLC7A11 signal axis. Journal of Functional Foods 2024; 116: 106138 doi: 10.1016/j.jff.2024.106138
|
| 14 |
Nicolas Weiss, Pierre Barbier Saint Hilaire, Benoit Colsch, Foucauld Isnard, Suleiman Attala, Augustin Schaefer, Maria del Mar Amador, Marika Rudler, Foudil Lamari, Frédéric Sedel, Dominique Thabut, Christophe Junot. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. Journal of Hepatology 2016; 65(6): 1120 doi: 10.1016/j.jhep.2016.07.046
|
| 15 |
Kumar Sandrasegaran, Enming Cui, Reem Elkady, Pauley Gasparis, Gitasree Borthakur, Mark Tann, Suthat Liangpunsakul. Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?. European Radiology 2018; 28(10): 4215 doi: 10.1007/s00330-018-5366-6
|
| 16 |
João Guilherme M. Pontes, Antonio Jadson M. Brasil, Guilherme C. F. Cruz, Rafael N. de Souza, Ljubica Tasic. NMR-based metabolomics strategies: plants, animals and humans. Analytical Methods 2017; 9(7): 1078 doi: 10.1039/C6AY03102A
|
| 17 |
Zhi Chen, Dong Xi, Tao Chen, Dao-Feng Yang, Yi-Min Mao. Acute Exacerbation of Chronic Hepatitis B. 2019; : 49 doi: 10.1007/978-94-024-1606-0_2
|